Cystamine and sildenafil in treatment of right ventricular hypertrophy in rats with pulmonary hypertension

L. H. Markvardsen, J. D. Baandrup, M. Kruhoffer, U. Simonsen (Aarhus C, Aarhus N, Denmark)

Source: Annual Congress 2008 - Pulmonary hypertension II
Session: Pulmonary hypertension II
Session type: Thematic Poster Session
Number: 1033
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. H. Markvardsen, J. D. Baandrup, M. Kruhoffer, U. Simonsen (Aarhus C, Aarhus N, Denmark). Cystamine and sildenafil in treatment of right ventricular hypertrophy in rats with pulmonary hypertension. Eur Respir J 2008; 32: Suppl. 52, 1033

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bosentan combined with sildenafil prevents right ventricular hypoxia in pulmonary arterial hypertension
Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Year: 2008


Macitentan in pulmonary hypertension due to left ventricular dysfunction
Source: Eur Respir J, 51 (2) 1701886; 10.1183/13993003.01886-2017
Year: 2018



Lodenafil improves hemodynamics and right ventricular remodeling in monocrotaline-induced model of pulmonary arterial hypertension in rats
Source: Annual Congress 2010 - Experimental pulmonary hypertension
Year: 2010

Effect of sitaxentan on haemodynamics and right ventricular hypertrophy in monocrotaline-induced pulmonary arterial hypertension (PAH)
Source: Annual Congress 2008 - Pulmonary vascular biology
Year: 2008


Urocortin-2 improves right ventricular function and attenuates experimental pulmonary arterial hypertension
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018


The evaluation of right and left ventricular dysfunction in COPD patients with pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 250s
Year: 2001

Increased right ventricular cardiomyocyte stiffness in patients with pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology
Year: 2012

How prostacyclin therapy improves right ventricular function in pulmonary arterial hypertension
Source: Eur Respir J, 50 (2) 1700764; 10.1183/13993003.00764-2017
Year: 2017



Pulmonary hypertension, right and left ventricular dysfunction in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 404s
Year: 2006

Right ventricular dyssynchrony and exercise capacity in idiopathic pulmonary arterial hypertension
Source: Eur Respir J, 49 (6) 1601419; 10.1183/13993003.01419-2016
Year: 2017



Amelioration of right ventricular morphology and systolic function in patients with severe group 3 pulmonary hypertension treated with pulmonary vasodilators
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015


Isolated diastolic dysfunction of right ventricle: stress-induced pulmonary hypertension
Source: Eur Respir J 2008; 31: 475-476
Year: 2008


Combining bosentan and sildenafil improves mitochondrial capacity and restores right ventricular contractility in established pulmonary hypertension
Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension
Year: 2007


Iloprost reverses established fibrosis in experimental right ventricular failure
Source: Eur Respir J 2015; 45: 449-462
Year: 2015



The heat shock protein 90 inhibitor, 17-AAG, ameliorates pulmonary arteriolar and right ventricular hypertrophy in monocrotaline-induced pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary circulation II
Year: 2009

Right ventricular stiffness impairs right atrial function in pulmonary arterial hypertension
Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension
Year: 2020




More on the right ventricle in pulmonary hypertension
Source: Eur Respir J 2015; 45: 33-35
Year: 2015


Right ventricular dysfunction in patients with pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 335s
Year: 2005

Digoxin effect in mortality associated to right ventricular dysfunction in patients with pulmonary hypertension
Source: International Congress 2019 – Pulmonary hypertension: clinical
Year: 2019